Valuation : Zoetis Inc.

Market Cap 31.33B 26.96B 25.36B 23.17B 43.34B 2,958B 43.46B 300B 116B 1,518B 118B 115B 4,889B P/E 2026 *
13.5x
P/E 2027 * 12.7x
Enterprise Value 38.45B 33.08B 31.13B 28.43B 53.19B 3,630B 53.34B 368B 143B 1,862B 144B 141B 6,000B EV / Sales 2026 *
4.16x
EV / Sales 2027 * 3.99x
Free-Float
82.35%
Yield 2026 *
2.79%
Yield 2027 * 2.98%
1 day+0.12%
1 week-1.25%
Current month-1.79%
1 month+2.24%
3 months-6.38%
6 months-38.81%
Current year-39.55%
1 week 64.36
Extreme 64.36
67.2
1 month 61.5
Extreme 61.5
68.38
Current year 61.5
Extreme 61.5
114.98
1 year 61.5
Extreme 61.5
132.56
3 years 61.5
Extreme 61.5
185
5 years 61.5
Extreme 61.5
221
10 years 61.5
Extreme 61.5
221
Manager TitleAgeSince
Chief Executive Officer 54 01/01/2020
Director of Finance/CFO 53 17/08/2026
Chief Tech/Sci/R&D Officer 49 01/01/2026
Director TitleAgeSince
Director/Board Member 68 01/07/2012
Director/Board Member 68 01/01/2013
Chairman 73 26/06/2013
Change 5-day change 1-year change 3-year change Capi.($)
+0.12%-1.25% - - 31.33B
-0.63%-1.98%-50.55%-60.19% 31.33B
+0.33%+1.62%+32.94%+102.81% 12.24B
+3.00%-2.83%-12.37%+3.75% 3.93B
-0.62%-1.39%-1.54%+19.03% 3.11B
-0.16%-2.84%+50.55%+30.85% 2B
-1.01%-4.06%+12.59%+9.01% 1.89B
-0.86%+1.54%-3.04%+184.81% 1.55B
+2.49%+2.25%-18.22%-4.64% 1.2B
+2.53%+0.15%-7.26%-41.03% 1.05B
Average +0.52%-0.48%+0.34%+27.16% 6.48B
Weighted average by Cap. -0.00%-0.97%-19.61%-4.05%

Financials

2026 *2027 *
Net sales 9.23B 7.95B 7.48B 6.83B 12.78B 872B 12.81B 88.34B 34.28B 447B 34.67B 33.92B 1,441B 9.46B 8.14B 7.66B 7B 13.09B 893B 13.12B 90.5B 35.12B 458B 35.52B 34.75B 1,476B
Net income 2.36B 2.03B 1.91B 1.75B 3.27B 223B 3.28B 22.59B 8.77B 114B 8.87B 8.67B 368B 2.38B 2.05B 1.93B 1.76B 3.29B 225B 3.3B 22.78B 8.84B 115B 8.94B 8.75B 372B
Net Debt 7.12B 6.13B 5.76B 5.27B 9.85B 672B 9.88B 68.12B 26.43B 345B 26.74B 26.16B 1,111B 6.38B 5.49B 5.16B 4.72B 8.83B 602B 8.85B 61.03B 23.68B 309B 23.95B 23.43B 995B
Logo Zoetis Inc.
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - companion animal (67.8%): cats and dogs (95.5% of net sales) and horses (4.5%); - livestock (31.3%): cattle (52.8% of sales), poultry (18.2%), swine (17.8%), fish (8.4%) and other (2.8%); - other (0.9%). Net sales break down by family of products into parasiticides (23.3%), vaccines (19.7%), dermatological products (17.9%), anti-infectives (11.9%), pain relievers (9.2%), diagnostic products (4.2%), medicated feed additives (3.2%) and other (10.6%). At the end of 2024, the group has 22 production sites worldwide. The United States accounts for 54.8% of net sales.
Employees
14,500
Date Price Change Volume
04/09/26 €64.86 +0.12% 932
03/09/26 €64.78 -3.08% 1,655
02/09/26 €66.84 +0.57% 799
01/09/26 €66.46 +0.64% 793
31/08/26 €66.04 +0.55% 1,459
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
75.81USD
Average target price
96.00USD
Spread / Average Target
+26.63%

Quarterly revenue - Rate of surprise